Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. usa texas
  4. therapeutic antibody development
Show results for
Products

Companies


Refine by
Locations
Back to All Locations

  • USA
  • Texas
Brands

  • immatics tcer
  • kalaris
  • lung therapeutics

Therapeutic Antibody Development Equipment Supplied In Usa Texas

3 equipment items found
In TexasAvailable In TexasNear Texas

Kalaris - TH103 for Retinal Disease Treatment

Kalaris - TH103 for Retinal Disease Treatment

Manufactured by:Kalaris   based inWaltham, MASSACHUSETTS (USA)
Kalaris Therapeutics is focused on developing innovative treatments for retinal diseases, aiming to reduce the burden of frequent clinical visits for patients with retinal neovascular and exudative conditions. Their lead product, TH103, is a fully humanized, recombinant fusion protein designed for intravitreal delivery as an anti-VEGF agent. TH103 functions as a soluble decoy receptor, ...
CONTACT SUPPLIER

Lung Therapeutics - Model LTI-03 - Revolutionary Compound for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Lung Therapeutics - Model LTI-03 - Revolutionary Compound for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Manufactured by:Lung Therapeutics, Inc.   based inAustin, TEXAS (USA)
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by progressive tissue scarring that prevents proper lung function. LTI-03 operates through a novel mechanism of action (MOA) that is unlike any MOA seen in the therapeutic candidates of today. By targeting healthy epithelial cells, LTI-03 promotes the protection of lung epithelium while inhibiting fibroblast growth and ...
CONTACT SUPPLIER

Immatics TCER - Bispecific T cell Engaging Receptors

Immatics TCER - Bispecific T cell Engaging Receptors

Manufactured by:Immatics N.V.   based inTuebingen, GERMANY
Bispecific T cell engaging receptors (TCER®) are off-the-shelf biologics that leverage the body’s immune system by redirecting and activating T cells towards cancer cells expressing specific tumor targets. The design of these novel biologics allows any T cell in the body to become activated and attack the tumor, regardless of the T cells’ intrinsic ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT